The report (http://www.researchmoz.us/recombinant-coagulation-factors-2013-the-race-to-market-and-for-market-shares-a-technology-and-pipeline-assessment-and-corporate-benchmarking-analysis-report.html) “Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares: Technology & Pipeline Assessment and Corporate Benchmarking Analysis” of June 2013 describes a market forecast based on growth of historical sales of recombinant coagulation factors. The report evaluates reasons for failures of novel recombinant coagulation factors and provides detailed profiles of active recombinant coagulation factors in clinical development. Preclinical projects are valued on the basis of the underlying technologies. Emerging alternative therapeutic approaches are described and assessed.
2) The US Biotechnology Market Outlook to 2016
The report titled (http://www.researchmoz.us/the-us-biotechnology-market-outlook-to-2016-future-growth-led-by-surging-biotech-application-in-agriculture-health-and-industrial-sector-report.html) ‘The US Biotechnology Market Outlook to 2016 – Future Growth Led by Surging Biotech Application in Agriculture, Health and Industrial Sector’ provides a detailed description of the biotechnology market scenario in the US and a comprehensive analysis of the various qualitative and quantitative factors that are influencing the market. The report depicts the size of the biotech industry, biopharmaceuticals, bio
Copyright©2012 Vocus, Inc.
All rights reserved